glp-1 drugs injection The Latest on GLP-1s | Lexington Medical Center Blog Obesity drug cuts opiate craving
Description
No injections needed just a daily tablet
Studies show GLP-1 reduces glucagon levels and improves glucose regulation
In a trial, people lost 75% fat and 25% muscle.
Meanwhile, Eli Lilly is advancing orforglipron, the first small-molecule GLP-1 receptor agonist for obesity
Since type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimers disease (AD) and both have the same pathogenesis (e.g., insulin resistance), drugs used to treat T2DM have been gradually found to reduce the progression of AD in AD models
